GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review – 2015 Now Available at iData Insights GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2015 Summary Global Markets Direct s, GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2015 , provides an overview of the GeneScience Pharmaceuticals Co., Ltd. s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of GeneScience Pharmaceuticals Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of GeneScience Pharmaceuticals Co., Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of GeneScience Pharmaceuticals Co., Ltd.s human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products along with the product s developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the GeneScience Pharmaceuticals Co., Ltd. s pipeline products Reasons to buy - Evaluate GeneScience Pharmaceuticals Co., Ltd. s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of GeneScience Pharmaceuticals Co., Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the GeneScience Pharmaceuticals Co., Ltd. s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of GeneScience Pharmaceuticals Co., Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of GeneScience Pharmaceuticals Co., Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive 1
projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of GeneScience Pharmaceuticals Co., Ltd. and identify potential opportunities in those areas Avoid Intellectual Property Rights related issues Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landingpage.php?id=124226/neurovive-pharmaceutical-ab-product-pipeline-review-2015 To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landingpage.php?id=124226/neurovive-pharmaceutical-ab-product-pipeline-review-2015 Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 GeneScience Pharmaceutical AB Snapshot 5 GeneScience Pharmaceutical AB Overview 5 Key Information 5 Key Facts 5 GeneScience Pharmaceutical AB - Research and Development Overview 6 Key Therapeutic Areas 6 NeuroVive Pharmaceutical AB - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Out-Licensed Products 10 Out-Licensed Products/Combination Treatment Modalities 11 GeneScience Pharmaceutical AB - Pipeline Products Glance 12 GeneScience Pharmaceutical AB - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 GeneScience Pharmaceutical AB - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 GeneScience Pharmaceutical AB - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 2
Discovery Products/Combination Treatment Modalities 15 GeneScience Pharmaceutical AB - Drug Profiles 16 cyclosporine 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 NVP-014 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 NVP-019 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 NVP-015 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 GeneScience Pharmaceutical AB - Pipeline Analysis 22 GeneScience Pharmaceutical AB - Pipeline Products by Target 22 GeneScience Pharmaceutical AB - Pipeline Products by Route of Administration 23 GeneScience Pharmaceutical AB - Pipeline Products by Molecule Type 24 GeneScience Pharmaceutical AB - Pipeline Products by Mechanism of Action 25 GeneScience Pharmaceutical AB - Recent Pipeline Updates 26 GeneScience Pharmaceutical AB - Dormant Projects 29 GeneScience Pharmaceutical AB - Discontinued Pipeline Products 30
3
Discontinued Pipeline Product Profiles 30 cyclosporine 30 GeneScience Pharmaceutical AB - Locations And Subsidiaries 31 Head Office 31 Other Locations & Subsidiaries 31 Appendix 32 Methodology 32 Coverage 32 Secondary Research 32 Primary Research 32 Expert Panel Validation 32 Contact Us 32 Disclaimer 33 Read More http://www.idatainsights.com/reports-landing-page.php?id=124226/neurovivepharmaceutical-ab-product-pipeline-review-2015 About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line. ContactUs: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects
4